메뉴 건너뛰기




Volumn 7, Issue 27, 2003, Pages 3668-3670

Plasma coupling factor 6 level and its relationships with atrial natriuretic peptide and endothelin in patients with essential hypertension

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE; ENDOTHELIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNCOUPLING PROTEIN 6;

EID: 2442489981     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (8)
  • 1
    • 0034808298 scopus 로고    scopus 로고
    • Clinically important factors influencing endothelial function
    • Vapaatalo H, Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 2001; 7(5): 1075-85
    • (2001) Med. Sci. Monit. , vol.7 , Issue.5 , pp. 1075-1085
    • Vapaatalo, H.1    Mervaala, E.2
  • 2
    • 0034789839 scopus 로고    scopus 로고
    • Mitochondrial coupling factor 6 a potent endogenous vasoconstrictor
    • Osanai T, Tanaka M, Kamada T, et al. Mitochondrial coupling factor 6 a potent endogenous vasoconstrictor. J Clin Invest 2001; 108(7): 1023-30
    • (2001) J. Clin. Invest. , vol.108 , Issue.7 , pp. 1023-1030
    • Osanai, T.1    Tanaka, M.2    Kamada, T.3
  • 3
    • 0035910041 scopus 로고    scopus 로고
    • Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress
    • Osanai T, Okada S, Sirato K, et al. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 2001; 104(25): 3132-6
    • (2001) Circulation , vol.104 , Issue.25 , pp. 3132-3136
    • Osanai, T.1    Okada, S.2    Sirato, K.3
  • 4
    • 2442597571 scopus 로고    scopus 로고
    • Alteration of mitochondrial coupling factor 6 in essential hypertension
    • Ren YS, Jiang HF, Jiang W, et al. Alteration of mitochondrial coupling factor 6 in essential hypertension. Gaoxueya Zazhi 2003; 11(1): 19-21
    • (2003) Gaoxueya Zazhi , vol.11 , Issue.1 , pp. 19-21
    • Ren, Y.S.1    Jiang, H.F.2    Jiang, W.3
  • 5
    • 0037407538 scopus 로고    scopus 로고
    • Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction
    • Quaschning T, Galle J, Wanner C. Vasopeptidase inhibition: A new treatment approach for endothelial dysfunction. Kidney Int Suppl 2003; (84): 54-7
    • (2003) Kidney Int. Suppl. , Issue.84 , pp. 54-57
    • Quaschning, T.1    Galle, J.2    Wanner, C.3
  • 6
    • 0037022277 scopus 로고    scopus 로고
    • Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure
    • Cataliotti A, Boerrigter G, Chen HH, et al. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure. Circulation 2002; 105(5): 639-44
    • (2002) Circulation , vol.105 , Issue.5 , pp. 639-644
    • Cataliotti, A.1    Boerrigter, G.2    Chen, H.H.3
  • 7
    • 2442475833 scopus 로고    scopus 로고
    • Correlation between endothelial relaxation function and endothelin in old hypertensive patients
    • Yang YR, Lin T, Wu X, et al. Correlation between endothelial relaxation function and endothelin in old hypertensive patients. Zhongguo Linchuang Kangfu 2002; 6 (19): 2898
    • (2002) Zhongguo Linchuang Kangfu , vol.6 , Issue.19 , pp. 2898
    • Yang, Y.R.1    Lin, T.2    Wu, X.3
  • 8
    • 2442538243 scopus 로고    scopus 로고
    • Plasma neuropeptide Y and endothelin levels and nailfold microcirculation in patients with essential hypertension and cerebral apoplexy
    • Wang YW, Wang SY, Zhu YL, et al. Plasma neuropeptide Y and endothelin levels and nailfold microcirculation in patients with essential hypertension and cerebral apoplexy. Zhongguo Linchuang Kangfu 2003; 7(9): 1366-9
    • (2003) Zhongguo Linchuang Kangfu , vol.7 , Issue.9 , pp. 1366-1369
    • Wang, Y.W.1    Wang, S.Y.2    Zhu, Y.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.